Response Genetics' Q1 Revenues Increase 40 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Molecular diagnostics company Response Genetics today reported a 40 percent increase year over year in its first-quarter revenues.

The Los Angeles-based company said that for the three months ended March 31, revenues rose to $5.6 million from $4.0 million. Revenues from its pharmaceutical clients increased 137 percent year over year, while revenues generated by ResponseDX products rose 8 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.